These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33966143)
1. Association of serum uric acid with mortality and cardiovascular outcomes in patients with hypertension: a meta-analysis. Yang Y; Zhang X; Jin Z; Zhao Q J Thromb Thrombolysis; 2021 Nov; 52(4):1084-1093. PubMed ID: 33966143 [TBL] [Abstract][Full Text] [Related]
2. Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: A meta-analysis. Wang R; Song Y; Yan Y; Ding Z Atherosclerosis; 2016 Nov; 254():193-199. PubMed ID: 27755985 [TBL] [Abstract][Full Text] [Related]
3. Association between blood phosphorus level and adverse outcomes in patients with coronary artery disease: A meta-analysis. Zhu L; Liu Z; Zhang S; Wang X; Fan Y Heliyon; 2024 Oct; 10(19):e38565. PubMed ID: 39397948 [TBL] [Abstract][Full Text] [Related]
4. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). Franse LV; Pahor M; Di Bari M; Shorr RI; Wan JY; Somes GW; Applegate WB J Hypertens; 2000 Aug; 18(8):1149-54. PubMed ID: 10954008 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor-23 as a biomarker of adverse outcomes in patients with coronary artery disease: a meta-analysis. Zheng S; Wang C; Yan H; Xu M; Du Y Biomarkers; 2022 Jun; 27(4):299-305. PubMed ID: 35254176 [TBL] [Abstract][Full Text] [Related]
6. Which patients with coronary artery disease should include oral nitrates on their discharge medication list? Xueying C; Hua Z; Lujing Z; Ruomeng L; Wen D; Anyong C; Ronghua G; Ying G; Shufang Z; Guoliang Y; Lixin L; Shijun W; Shaohui Z; Lijun G Acta Cardiol; 2024 Apr; 79(2):136-148. PubMed ID: 37961760 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of lipoprotein (a) level in patients with coronary artery disease: a meta-analysis. Wang Z; Zhai X; Xue M; Cheng W; Hu H Lipids Health Dis; 2019 Jul; 18(1):150. PubMed ID: 31286992 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Baseline d-Dimer Level in Patients With Coronary Artery Disease: A Meta-Analysis. Zhang H; Yao J; Huang Z; Zhao Z; Wang B; Zhao J Angiology; 2022 Jan; 73(1):18-25. PubMed ID: 34078130 [TBL] [Abstract][Full Text] [Related]
10. Association of microalbuminuria and adverse outcomes in hypertensive patients: a meta-analysis. Hong Z; Jiang Y; Liu P; Zhang L Int Urol Nephrol; 2021 Nov; 53(11):2311-2319. PubMed ID: 33674949 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of asymmetric dimethylarginine in patients with coronary artery disease: A meta-analysis. Ye J; Dai Y; Mao H; Zheng W; Zhang J Nitric Oxide; 2021 May; 109-110():50-56. PubMed ID: 33684543 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis. Luo JW; Duan WH; Yu YQ; Song L; Shi DZ Front Cardiovasc Med; 2021; 8():774781. PubMed ID: 34926622 [No Abstract] [Full Text] [Related]
13. Association of growth differentiation factor-15 level with adverse outcomes in patients with stable coronary artery disease: A meta-analysis. Li T; Chen Y; Ye T; Zheng L; Chen L; Fan Y; Lin B Atheroscler Plus; 2022 Jan; 47():1-7. PubMed ID: 36643602 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of adiponectin level in patients with coronary artery disease: a systematic review and meta-analysis. Yang L; Li B; Zhao Y; Zhang Z Lipids Health Dis; 2019 Dec; 18(1):227. PubMed ID: 31870374 [TBL] [Abstract][Full Text] [Related]
15. Serum Uric Acid Levels and Outcomes After Acute Ischemic Stroke. Wang Z; Lin Y; Liu Y; Chen Y; Wang B; Li C; Yan S; Wang Y; Zhao W Mol Neurobiol; 2016 Apr; 53(3):1753-1759. PubMed ID: 25744569 [TBL] [Abstract][Full Text] [Related]
16. The URRAH study. Del Pinto R; Viazzi F; Pontremoli R; Ferri C; Carubbi F; Russo E Panminerva Med; 2021 Dec; 63(4):416-423. PubMed ID: 33765764 [TBL] [Abstract][Full Text] [Related]
17. U-Shaped Relationship Between Cardiovascular Mortality and Serum Uric Acid May Be Attributed to Stroke- and Heart-Specific Mortality, Respectively, Among Hypertensive Patients: A Nationally Representative Cohort Study. You H; Chen K; Han P; Yue C; Zhao X Med Sci Monit; 2021 Feb; 27():e928937. PubMed ID: 33534782 [TBL] [Abstract][Full Text] [Related]
18. Association of metabolic syndrome with cardiovascular outcomes in hypertensive patients: a systematic review and meta-analysis. Liu J; Chen Y; Cai K; Gong Y J Endocrinol Invest; 2021 Nov; 44(11):2333-2340. PubMed ID: 34152572 [TBL] [Abstract][Full Text] [Related]
19. Elevated serum uric acid and risk of cardiovascular or all-cause mortality in maintenance hemodialysis patients: A meta-analysis. Wang H; Liu J; Xie D; Liu H; Zhen L; Guo D; Liu X Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):372-381. PubMed ID: 33485730 [TBL] [Abstract][Full Text] [Related]
20. Uric acid and risk of heart failure: a systematic review and meta-analysis. Huang H; Huang B; Li Y; Huang Y; Li J; Yao H; Jing X; Chen J; Wang J Eur J Heart Fail; 2014 Jan; 16(1):15-24. PubMed ID: 23933579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]